Equities

Seer Inc

SEER:NSQ

Seer Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.03
  • Today's Change0.01 / 0.50%
  • Shares traded223.00k
  • 1 Year change+11.54%
  • Beta1.4449
Data delayed at least 15 minutes, as of Nov 05 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.

  • Revenue in USD (TTM)14.74m
  • Net income in USD-82.42m
  • Incorporated2017
  • Employees147.00
  • Location
    Seer Inc3800 Bridge Parkway, Suite 102REDWOOD CITY 94065United StatesUSA
  • Phone+1 (650) 453-0000
  • Fax+1 (302) 655-5049
  • Websitehttps://seer.bio/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sigma Koki Co Ltd72.72m3.82m70.99m526.0017.430.588711.180.976282.0482.041,562.132,429.290.52612.173.8121,032,940.002.765.273.236.1137.8538.645.259.553.23--0.031630.29-1.364.39-53.98-3.666.830.9806
Micro Systemation AB (publ)37.67m1.31m87.11m191.0067.718.3632.712.310.75910.759121.846.151.442.884.951,914,450.005.009.319.1018.1593.0488.713.475.971.696.640.266362.5714.876.5375.111.57-15.61-7.37
Trajan Group Holdings Ltd102.07m-16.68m115.29m600.00--1.70--1.13-0.1664-0.16641.020.67570.74353.157.09258,371.70-12.15-2.57-16.57-3.6739.1038.94-16.34-3.110.46820.57410.3532---4.4018.00-1,440.87--2.59--
Nynomic AG122.71m10.30m120.52m590.0011.691.097.350.98221.451.4517.2215.460.77321.116.90210,867.306.937.238.959.6466.8461.008.968.171.5614.390.17370.001.0211.9624.836.4438.05--
Seer Inc14.74m-82.42m124.09m147.00--0.3502--8.42-1.28-1.280.22925.770.0341.172.46100,258.50-18.99-16.65-19.74-17.0949.19---559.21-756.7117.15--0.00--7.54--7.20--112.67--
Gooch & Housego plc173.79m2.71m162.39m1.03k59.151.149.120.93440.0822-0.30135.234.270.78822.604.27130,215.501.231.551.401.8230.1132.251.562.171.953.680.247581.408.201.58341.64-7.620.25612.84
Basler AG196.13m-16.87m182.63m900.00--1.2122.900.9311-0.5066-0.50665.874.410.67682.155.31170,265.30-5.825.33-6.896.5042.6649.13-8.605.551.73--0.3775.22-25.496.07-164.63---5.61--
Data as of Nov 05 2024. Currency figures normalised to Seer Inc's reporting currency: US Dollar USD

Institutional shareholders

30.35%Per cent of shares held by top holders
HolderShares% Held
Invus Public Equities Advisors LLCas of 25 Jul 20244.20m7.31%
The Vanguard Group, Inc.as of 30 Jun 20242.33m4.06%
Tang Capital Management LLCas of 30 Jun 20242.30m4.01%
Capital Research & Management Co. (World Investors)as of 30 Jun 20242.06m3.58%
Acadian Asset Management LLCas of 30 Jun 20241.80m3.14%
Citigroup Global Markets, Inc. (Investment Management)as of 30 Jun 20241.29m2.25%
BlackRock Fund Advisorsas of 30 Jun 20241.28m2.23%
Millennium Management LLCas of 30 Jun 2024904.83k1.58%
Fidelity Management & Research Co. LLCas of 30 Jun 2024709.12k1.24%
BlackRock Advisors LLCas of 30 Jun 2024548.05k0.96%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.